ME01876B - Upotreba antagonističkih anti-cd40 monoklonskih antitjela - Google Patents

Upotreba antagonističkih anti-cd40 monoklonskih antitjela

Info

Publication number
ME01876B
ME01876B MEP-2013-130A MEP13013A ME01876B ME 01876 B ME01876 B ME 01876B ME P13013 A MEP13013 A ME P13013A ME 01876 B ME01876 B ME 01876B
Authority
ME
Montenegro
Prior art keywords
monoclonal antibodies
antagonistic anti
antagonistic
monoclonal
antibodies
Prior art date
Application number
MEP-2013-130A
Other languages
English (en)
Inventor
Li Long
Mohammed Luqman
Asha Yabannavar
Isabel Zaror
Sang Hoon Lee
Deborah Hurst
Bao-Lu Chen
Xiaofeng Lu
Original Assignee
Novartis Vaccines & Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostics Inc filed Critical Novartis Vaccines & Diagnostics Inc
Priority claimed from EP09075395.5A external-priority patent/EP2149585B1/en
Publication of ME01876B publication Critical patent/ME01876B/me

Links

MEP-2013-130A 2003-11-04 2004-11-04 Upotreba antagonističkih anti-cd40 monoklonskih antitjela ME01876B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51733703A 2003-11-04 2003-11-04
US52557903A 2003-11-26 2003-11-26
US56571004A 2004-07-30 2004-07-30
EP09075395.5A EP2149585B1 (en) 2003-11-04 2004-11-04 Use of antagonistic anti-CD40 monoclonal antibodies

Publications (1)

Publication Number Publication Date
ME01876B true ME01876B (me) 2014-12-20

Family

ID=58463994

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-130A ME01876B (me) 2003-11-04 2004-11-04 Upotreba antagonističkih anti-cd40 monoklonskih antitjela

Country Status (2)

Country Link
CY (1) CY1114654T1 (me)
ME (1) ME01876B (me)

Also Published As

Publication number Publication date
CY1114654T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
PL1707627T3 (pl) Mutant antagonistycznego przeciwciała anty-CD40
IL149701A0 (en) Use of anti-ctla-4 antibodies
IL175935A0 (en) Solid forms of anti-egfr antibodies
IL177602A0 (en) Uses of anti-ctla-4 antibodies
SI1587542T1 (sl) Uporaba anti-cd100 protiteles
GB0305702D0 (en) Bispecific antibodies
IL179672A (en) Monoclonal antibodies against 3 cd human
IL191117A0 (en) Uses of anti-cd40 antibodies
AU2002251562A1 (en) Anti-CD40 monoclonal antibody
IL243914A0 (en) Antibodies against vegf
IL168304A (en) Human monoclonal antibodies against cd25
IL200604A0 (en) Human monoclonal antibodies against cd30
CY2012019I2 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
EP1658095A4 (en) ANTI-CD3 ANTIBODY DESIMMUNISE
IL205511A0 (en) Methods and compositions for the production of monoclonal antibodies
IL175608A0 (en) Antibodies
IL173557A0 (en) Variable antibodies
AU2003220079A8 (en) Uses of monoclonal antibody 8h9
AU2003277832A8 (en) Humanized tissue factor antibodies
IL172533A0 (en) Humanized anti-ccr2 antibodies and methods of use
ME01876B (me) Upotreba antagonističkih anti-cd40 monoklonskih antitjela
SI2149585T1 (sl) Uporaba antagonističnih ANTI-CD40 monoklonskih protiteles
EP1813668A4 (en) HYBRIDOM capable of producing a monoclonal anti-DECTIN-1 antibody
GB0415644D0 (en) Monoclonal antibody
GB0325391D0 (en) Human monoclonal antibodies